2-Exelixis-MDCSCO

 

Welcome to our virtual exhibit booth!

   

 

Exelis logo

Now Approved


About Us

Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website.

www.cabometyxhcp.com


Click the boxes below to access additional information.

Full Prescribing Information

EASE: Exelixis Access Services

Dosing and Administration Guide

Resources

Now Approved Letter

CELESTIAL Trial Publication



Andrea Hallet Headshot
Andrea Hallett
Territory: MD/DC/VA
Cell: (410) 591-0915
ahallett@exelixis.com


Jenny Maginnis Headshot
Jenny Maginnis
Territory: MD
Cell: (410) 271-6580
jmaginnis@exelixis.com


Kristina Meagher Headshot
Kristina Meagher
Territory: MD/DC/VA
Cell: (410) 487-4149
kmeagher@exelixis.com


Contact Us
 

_____________________________________________